Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study
NCT: NCT06329310 · RECRUITING
Brief Summary
A prospective, single arm, non-randomized feasibility study to confirm the safety and performance of the Xeltis Hemodialysis Access conduit, aXess-E, in subjects older than 18 years with end-stage renal disease, who plan to undergo hemodialysis for at least the first 6 months after study access creation.
Frequently Asked Questions
What is Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study?
Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study is a clinical trial registered under NCT06329310. Current status: RECRUITING.
What is the status of NCT06329310?
The current status of NCT06329310 (Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study) is: RECRUITING.
When did Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study start?
Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study started on 2024-12-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.